Open Access<p>Resection as first-line therapy for large hepatic sclerosing hemangioma: a case report</p>
Author(s) -
Li Xu,
Xu Yang,
Ke Shi,
Xuemei Ding,
Shaohong Wang,
Jun Gao,
Wenbing Sun
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s217528
Subject(s) - medicine , hemangioma , ablation , first line , radiofrequency ablation , cavernous hemangiomas , rare disease , resection , first line therapy , radiology , pathology , disease , surgery
Hepatic sclerosing hemangioma is a rare benign disease that occurs in association with hepatic cavernous hemangioma degeneration and sclerosis. Recent studies have shown that radiofrequency (RF) ablation is an alternative treatment for hepatic cavernous hemangiomas, even for large hemangiomas (≥10 cm). However, RF ablation might not be suitable to treat large sclerosing hemangiomas. We herein report the successful surgical removal of a large hepatic sclerosing hemangioma after RF ablation treatment failure in a 65-year-old man. In conclusion, we suggest that resection should be chosen as a first-line therapy for the disease.